Plain-English translation of NCT07347743 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether Limosilactobacillus reuteri, a type of probiotic (beneficial bacteria), can help prevent colic and excessive crying in newborns when given starting in the first week of life. Researchers have seen promising results with this medication in other studies, and this trial will test whether it is safe and effective when given to healthy newborns for the first three months of their lives.
Many newborns experience excessive crying and colic, which can be very stressful for parents and families. Recent research suggests that this medication may help reduce these symptoms, but more testing is needed to confirm whether starting treatment very early in life—even before colic develops—can prevent the problem from happening in the first place.
You likely qualify if…
You likely don't qualify if…
If enrolled, your infant will receive either the probiotic supplement or a placebo (inactive treatment), both with added vitamin D, once daily for up to three months. You will have study visits at enrollment, 6 weeks, 3 months, and a follow-up call at one year. You'll also keep a daily diary of your infant's crying and fussiness, and the research team may call you to check in based on what you record.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
Belgium